NM_016156.6:c.1741A>G
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBP6
The NM_016156.6(MTMR2):āc.1741A>Gā(p.Ile581Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000688 in 1,612,804 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_016156.6 missense
Scores
Clinical Significance
Conservation
Publications
- demyelinating hereditary motor and sensory neuropathyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Charcot-Marie-Tooth disease type 4B1Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.000112  AC: 17AN: 151786Hom.:  0  Cov.: 32 show subpopulations 
GnomAD2 exomes  AF:  0.0000518  AC: 13AN: 251108 AF XY:  0.0000589   show subpopulations 
GnomAD4 exome  AF:  0.0000643  AC: 94AN: 1460900Hom.:  0  Cov.: 32 AF XY:  0.0000537  AC XY: 39AN XY: 726752 show subpopulations 
Age Distribution
GnomAD4 genome  0.000112  AC: 17AN: 151904Hom.:  0  Cov.: 32 AF XY:  0.000108  AC XY: 8AN XY: 74278 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
Charcot-Marie-Tooth disease type 4B1    Uncertain:1 
The MTMR2 c.1741A>G; p.Ile581Val variant (rs149476960), to our knowledge, is not reported in the medical literature or gene specific databases. The variant is listed in the ClinVar database (Variation ID: 543419) and is found in the general population with an overall allele frequency of 0.006% (16/282,470 alleles) in the Genome Aggregation Database. The isoleucine at codon 581 is moderately conserved and computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.275). Due to limited information, the clinical significance of the p.Ile581Val variant is uncertain at this time. -
not provided    Uncertain:1 
Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; In silico analysis, which includes splice predictors and evolutionary conservation, suggests this variant may impact gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown.; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 32376792) -
Charcot-Marie-Tooth disease type 4    Uncertain:1 
This sequence change replaces isoleucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 581 of the MTMR2 protein (p.Ile581Val). This variant is present in population databases (rs149476960, gnomAD 0.01%). This missense change has been observed in individual(s) with clinical features of Charcot-Marie-Tooth disease (PMID: 32376792). ClinVar contains an entry for this variant (Variation ID: 543419). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The valine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Charcot-Marie-Tooth disease    Benign:1 
- -
Inborn genetic diseases    Benign:1 
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at